HRC Fertility Elevates Dr. Robert Boostanfar to Chief Medical Officer

In his new capacity, Boostanfar will bridge the gap between executive leadership and the network’s clinical teams, focusing on physician engagement and the standardization of patient outcomes. His appointment signals a strategic push to integrate advanced clinical research directly into daily practice, building on his previous tenure as the organization's Director of Clinical Research, where he managed Phase III FDA trials.

CEO Sherif Hanna noted that Boostanfar’s leadership is central to maintaining clinical excellence as the network continues its rapid expansion. With over two decades of experience in reproductive medicine, Boostanfar is expected to prioritize evidence-based protocols that enhance both the patient experience and laboratory standards across the California and Nevada markets.